Literature DB >> 31759133

The effect of insulin dependent diabetes on bone metabolism and growth after spinal fusion.

Zachary NaPier1, Linda E A Kanim2, Trevor J Nelson3, Khosrowdad Salehi4, Yasaman Arabi4, Juliane D Glaeser4, Dmitriy Sheyn5, Melodie F Metzger6.   

Abstract

STUDY
DESIGN: Experimental animal model.
OBJECTIVE: The purpose of this study was to evaluate the hypothesis that insulin dependent diabetes mellitus (IDDM) will inhibit the formation of a solid bony union after spinal fusion surgery via an alteration of the microenvironment at the fusion site in a rat model. SUMMARY OF BACKGROUND DATA: Previous studies report diabetes mellitus (DM) and specifically IDDM as a risk factor for complications and poor surgical outcomes following spinal fusion.
METHODS: Twenty control and 22 diabetic rats were obtained at 5 weeks of age. At 20 weeks of age, all animals underwent posterolateral lumbar fusion surgery using a tailbone autograft with diabetic rats receiving an implantable time release insulin pellet. A subset of rats was sacrificed 1-week postsurgery for growth factor (PDGF, IGF-I, TGF-β, and VEGF) and proinflammatory cytokine ELISA analysis. All other rats were sacrificed 3-months postsurgery for fusion evaluation via manual palpation and micro CT. Glycated hemoglobin (HbA1c) was measured at surgery and sacrifice on all animals.
RESULTS: Compared with healthy rats undergoing spinal fusion, rats with IDDM demonstrated a significant reduction in manual palpation fusion rates (16.7% vs. 43%, p<.05). Average bone mineral density, bone volume, and bone volume fraction were also significantly reduced and negatively correlated to blood glucose levels. IL-1B, IL-5, IL-10, TNF-α, and KC/GRO were significantly elevated in fusion beds of IDDM rats.
CONCLUSIONS: This study demonstrates that rats with IDDM demonstrate a reduced rate and quality of spinal fusion with increased local levels of inflammatory cytokines. Targeted modalities are required to improve bone healing in this growing, high-risk population. CLINICAL SIGNIFICANCE: This is the first translational animal model of IDDM to evaluate the rate and quality of spinal fusion while controlling for other surgical and patient-related risk factors. Our findings demonstrate the complex nature by which IDDM impairs bone healing and highlight the need for additional basic science research to further elucidate this mechanism in order to develop more effective therapeutic interventions.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Growth factors; Insulin dependence; Nonunion; Pseudarthrosis; Spinal fusion

Mesh:

Year:  2019        PMID: 31759133      PMCID: PMC7234904          DOI: 10.1016/j.spinee.2019.11.011

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  36 in total

Review 1.  Biology of lumbar spine fusion and use of bone graft substitutes: present, future, and next generation.

Authors:  S D Boden
Journal:  Tissue Eng       Date:  2000-08

2.  The relationship between serum vitamin D levels and spinal fusion success: a quantitative analysis.

Authors:  Melodie F Metzger; Linda E A Kanim; Li Zhao; Samuel T Robinson; Rick B Delamarter
Journal:  Spine (Phila Pa 1976)       Date:  2015-04-15       Impact factor: 3.468

Review 3.  Fracture healing under healthy and inflammatory conditions.

Authors:  Lutz Claes; Stefan Recknagel; Anita Ignatius
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

4.  Instrumented posterior arthrodesis of the lumbar spine in patients with diabetes mellitus.

Authors:  J A Bendo; J Spivak; R Moskovich; M Neuwirth
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2000-08

5.  Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer.

Authors:  Aimalie L Hardaway; Mackenzie K Herroon; Erandi Rajagurubandara; Izabela Podgorski
Journal:  Clin Exp Metastasis       Date:  2015-03-24       Impact factor: 5.150

6.  Risk factors for postoperative spinal wound infections after spinal decompression and fusion surgeries.

Authors:  Anand Veeravagu; Chirag G Patil; Shivanand P Lad; Maxwell Boakye
Journal:  Spine (Phila Pa 1976)       Date:  2009-08-01       Impact factor: 3.468

7.  Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo.

Authors:  L Nguyen; F E Dewhirst; P V Hauschka; P Stashenko
Journal:  Lymphokine Cytokine Res       Date:  1991-04

8.  Perioperative complications of lumbar instrumentation and fusion in patients with diabetes mellitus.

Authors:  Steven D Glassman; Gary Alegre; Leah Carreon; John R Dimar; John R Johnson
Journal:  Spine J       Date:  2003 Nov-Dec       Impact factor: 4.166

9.  Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012.

Authors:  Andy Menke; Sarah Casagrande; Linda Geiss; Catherine C Cowie
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

Review 10.  The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis.

Authors:  Yong-Chao Qiao; Yin-Ling Chen; Yan-Hong Pan; Fang Tian; Yan Xu; Xiao-Xi Zhang; Hai-Lu Zhao
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

View more
  3 in total

1.  Patient and Surgical Factors Affecting Fusion Rates After Arthroscopic and Open Ankle Fusion: A Review of a High-Risk Cohort.

Authors:  Ashish B Shah; William Davis; Zachary L Littlefield; Sean Young; Bradley Alexander; Nicholas A Andrews; Ankit Khurana; Benjamin Cage; Tanvee Sinha; Gerald McGwin; Ashish Shah
Journal:  Indian J Orthop       Date:  2022-04-25       Impact factor: 1.033

2.  Diabetes management in spinal surgery.

Authors:  Michelot Michel; Brandon Lucke-Wold
Journal:  J Clin Images Med Case Rep       Date:  2022-06-22

3.  Preoperative Lymphocyte to Monocyte Ratio as a Predictive Biomarker for Disease Severity and Spinal Fusion Failure in Lumbar Degenerative Diseases Patients Undergoing Lumbar Fusion.

Authors:  Youfeng Guo; Haihong Zhao; Jiawei Lu; Haowei Xu; Tao Hu; Desheng Wu
Journal:  J Pain Res       Date:  2022-09-13       Impact factor: 2.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.